Showing results (361-370 of 381) with videos related to
Sort By:
Pageof 39
Journal of Immunology (Baltimore, Md. : 1950)|October 23, 2002
Prolonged maturation and enhanced transduction of dendritic cells migrated from human skin explants after in situ delivery of CD40-targeted adenoviral vectorsTanja D de Gruijl, Sylvia A Luykx-de Bakker, Bryan W Tillman, et al.Anti-Cancer Drugs|July 9, 2010
MDA-7/IL-24 as a cancer therapeutic: from bench to bedsidePaul Dent, Adly Yacoub, Hossein A Hamed, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 29, 2010
Selective transduction of dendritic cells in human lymph nodes and superior induction of high-avidity melanoma-reactive cytotoxic T cells by a CD40-targeted adenovirusBasav N Hangalapura, Dinja Oosterhoff, Shikhar Aggarwal, et al.Molecular Therapy. Oncology|May 25, 2026
Neural stem cell delivery of oncolytic CRAd-S-pk7 immunotherapy for stage 3 ovarian cancer: Dose-regimen studiesRachael Mooney, Gary Ngai, Gurmeet Kaur, et al.Nature Medicine|April 22, 2003
Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunityTyler J Curiel, Shuang Wei, Haidong Dong, et al.Expert Opinion on Investigational Drugs|August 20, 2011
Targeting Mcl-1 for the therapy of cancerBridget A Quinn, Rupesh Dash, Belal Azab, et al.Cytokine & Growth Factor Reviews|October 8, 2010
mda-7/IL-24: a unique member of the IL-10 gene family promoting cancer-targeted toxicityRupesh Dash, Sujit K Bhutia, Belal Azab, et al.Breast Cancer Research and Treatment|January 16, 2007
Mesenchymal stem cells as a vehicle for targeted delivery of CRAds to lung metastases of breast carcinomaMariam A Stoff-Khalili, Angel A Rivera, J Michael Mathis, et al.Pharmacology & Therapeutics|August 25, 2010
The development of MDA-7/IL-24 as a cancer therapeuticPaul Dent, Adly Yacoub, Hossein A Hamed, et al.Cell Reports|July 21, 2021
An intranasal vaccine durably protects against SARS-CoV-2 variants in miceAhmed O Hassan, Swathi Shrihari, Matthew J Gorman, et al.Pageof 39